The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Refining risk stratification in CMML: A comprehensive assessment of the IPSS-M and other molecularly informed models.
 
Luis E. Aguirre
No Relationships to Disclose
 
Akriti Gupta Jain
No Relationships to Disclose
 
Somedeb Ball
No Relationships to Disclose
 
Najla Al Ali
No Relationships to Disclose
 
David Andrew Sallman
Consulting or Advisory Role - Abbvie; Affimed Therapeutics; AvenCell; Bluebird Bio; Bristol-Myers Squibb; Gilead Sciences; Intellia Therapeutics; Intellisphere; Janssen; Jasper Therapeutics; Kite, a Gilead company; Magenta Therapeutics; Molecular Partners; Nkarta; Novartis; Precigen; Servier; Shattuck Labs; Syndax; Syros Pharmaceuticals; Takeda; Zentalis
Speakers' Bureau - Incyte
Research Funding - Aprea Therapeutics (Inst); Jazz Pharmaceuticals
 
Andrew Tucker Kuykendall
Leadership - Protagonist Therapeutics
Honoraria - Abbvie; Blueprint Medicines; Celgene/Bristol-Myers Squibb; CTI BioPharma Corp; Novartis; PharmaEssentia
Consulting or Advisory Role - Incyte; Protagonist Therapeutics
Speakers' Bureau - Blueprint Medicines; Celgene/Bristol-Myers Squibb; Novartis
Research Funding - Prelude Corporation; Protagonist Therapeutics
 
Onyee Chan
Consulting or Advisory Role - Abbvie
 
Zhuoer Xie
No Relationships to Disclose
 
Alison R. Walker
Employment - Medtronic (I)
Honoraria - Patient Resource
Consulting or Advisory Role - Patient Resource
Travel, Accommodations, Expenses - Gilead Sciences
 
Kendra Lynn Sweet
Leadership - Immundex (I)
Honoraria - Curio Science
Consulting or Advisory Role - BerGenBio; Bristol-Myers Squibb; Curis; Daiichi Sankyo/Lilly; Gilead Sciences; Jazz Pharmaceuticals; Mablytics; Nkarta; Novartis; Pfizer
Research Funding - Incyte (Inst); Jazz Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Jazz Pharmaceuticals
 
Jeffrey E. Lancet
Stock and Other Ownership Interests - Arvinas (I)
Consulting or Advisory Role - Abbvie; BerGenBio; Boxer Capital; Bristol-Myers Squibb/Celgene; Daiichi Sankyo; ElevateBio; Jazz Pharmaceuticals; Medtalks; Millennium; Novartis; RW Baird; Servier/Pfizer; The Dedham Group
 
Eric Padron
Honoraria - Blueprint Medicines; Stemline Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene; Pharmaessentia
Speakers' Bureau - Blueprint Medicines; Novartis; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb (Inst); Incyte (Inst); Kura Oncology (Inst)
 
Rami S. Komrokji
Stock and Other Ownership Interests - Abbvie
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; CTI BioPharma Corp; Geron; Gilead/Forty Seven; Jazz Pharmaceuticals; Novartis; Pharmaessentia; Taiho Oncology; Takeda
Speakers' Bureau - Abbvie; CTI BioPharma Corp; Jazz Pharmaceuticals; Pharmaessentia; SERVIER
Research Funding - Bristol-Myers Squibb/Celgene (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Jazz Pharmaceuticals; Pharmaessentia